Sendero Wealth Management LLC Has $3.68 Million Holdings in Icon Plc $ICLR

Sendero Wealth Management LLC increased its stake in shares of Icon Plc (NASDAQ:ICLR) by 26.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,004 shares of the medical research company’s stock after buying an additional 4,403 shares during the quarter. Sendero Wealth Management LLC’s holdings in Icon were worth $3,676,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Artisan Partners Limited Partnership grew its holdings in shares of Icon by 67.4% in the 2nd quarter. Artisan Partners Limited Partnership now owns 7,184,870 shares of the medical research company’s stock worth $1,045,039,000 after purchasing an additional 2,893,946 shares during the last quarter. Financiere des Professionnels Fonds d investissement inc. lifted its holdings in Icon by 31.0% during the 2nd quarter. Financiere des Professionnels Fonds d investissement inc. now owns 50,212 shares of the medical research company’s stock valued at $7,303,000 after purchasing an additional 11,894 shares during the last quarter. American Century Companies Inc. boosted its position in Icon by 11.2% in the second quarter. American Century Companies Inc. now owns 531,395 shares of the medical research company’s stock valued at $77,292,000 after buying an additional 53,458 shares in the last quarter. Equity Investment Corp bought a new stake in Icon during the second quarter worth about $82,264,000. Finally, DAVENPORT & Co LLC acquired a new stake in shares of Icon during the second quarter worth approximately $403,000. 95.61% of the stock is currently owned by institutional investors.

Icon Trading Down 1.7%

Shares of ICLR opened at $179.34 on Thursday. The stock’s fifty day simple moving average is $176.16 and its 200-day simple moving average is $167.76. The firm has a market capitalization of $14.48 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 3.38 and a beta of 1.25. Icon Plc has a 12-month low of $125.10 and a 12-month high of $228.29. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.31.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ICLR shares. Jefferies Financial Group downgraded Icon from a “buy” rating to a “hold” rating and reduced their target price for the stock from $220.00 to $175.00 in a report on Tuesday, September 9th. Cowen reissued a “hold” rating on shares of Icon in a research note on Friday, October 24th. Rothschild & Co Redburn upgraded Icon from a “neutral” rating to a “buy” rating and increased their target price for the stock from $184.00 to $236.00 in a report on Wednesday, September 3rd. Zacks Research raised Icon from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 25th. Finally, Bank of America downgraded shares of Icon from a “buy” rating to a “neutral” rating and set a $195.00 price target on the stock. in a research report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $205.31.

Icon Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.